Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action.

Menopause · 2018 · PMC6092106 · PMID 29533369

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The treatment effect size of MLE4901 above that achieved by placebo (percentage point reduction compared with placebo) was, however, highly significant for all outcomes.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.